Clinical Trials in Los Angeles, CA

Browse 242 Clinical Trials Los Angeles Across 1034 Cities
93 Phase 3 Trial · 8038 Clinical Trials Los Angeles Clinics

Display Results

All

Most EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Clinical Trials in Los Angeles, CA

Reviewed by Michael Gill, B. Sc.

Image of Elite Clinical Studies, LLC in Phoenix, United States.

Phase-Based Progress Estimates

Difamilast Ointmentfor Dermatitis

This is a Phase 3 Double Blind multi-center study conducted at 40 investigational sites in United States to assess the efficacy and safety of Difamilast Ointment 1% in subjects ≥2 years of age with mild to moderate atopic dermatitis.

Elite Clinical Studies, LLC (+12 Sites)Uma Srinivas Atmuri, MPharm MSAcrotech Biopharma Inc.

Image of Clinical Research Center of Alabama in Birmingham, United States.

Phase-Based Progress Estimates

Lebrikizumab (Cohort 1)for Dermatitis

This trial will test lebrikizumab, a potential new treatment for atopic dermatitis, in children aged 6 months to 18 years. The trial will measure the effect, safety and how well the body absorbs lebrikizumab.

Clinical Research Center of Alabama (+28 Sites)Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)Eli Lilly and Company

Image of Boise Kidney and Hypertension, PLLC in Nampa, United States.

Phase-Based Progress Estimates

RGLS8429for Polycystic Kidney, Autosomal Dominant

No Cost For Treatment

This trial is testing a new drug to treat ADPKD. The drug is being tested for safety and tolerability and its effects on biomarkers and kidney function.

No Cost For Treatment

Boise Kidney and Hypertension, PLLC (+8 Sites)Rekha Garg, MDRegulus Therapeutics Inc.

Image of PRG - Arizona Eye Institute in Sun City, United States.

Phase-Based Progress Estimates

AR-15512 Ophthalmic Solution (0.003%)for Dry Eye Syndromes

This will be a 12-month, multicenter, vehicle-controlled, double-masked, randomized Phase 3 study conducted at approximately 10 sites in the United States. All subjects enrolled will have dry eye disease (DED). The study will consist of a Baseline (Day 1) visit as well as visits at Day 14, Day 90, Day 180, Day 270, and Day 365 (Study Exit).

PRG - Arizona Eye Institute (+9 Sites)Michelle Senchyna, PhDAerie Pharmaceuticals

Image of Novo Nordisk Investigational Site in Pembroke Pines, United States.

Phase-Based Progress Estimates

Semaglutide Jfor Diabetes Mellitus, Type 2

This trial is testing a new way to make the diabetes drug semaglutide, to see if it controls blood sugar better than the current version.

Novo Nordisk Investigational Site (+45 Sites)Clinical Transparency (dept. 2834)Novo Nordisk A/S

Image of University of Texas Southwestern Wound Care Clinic in Dallas, United States.

Phase-Based Progress Estimates

SkinTEfor Diabetic Foot

This trial will test whether SkinTE, a skin cell transplant, is safe and effective for treating Wagner grade 2 diabetic foot ulcers.

University of Texas Southwestern Wound Care Clinic (+12 Sites)Lawrence Lavery, DPMPolarityTE

Image of Ronald Reagan Medical Center in Los Angeles, United States.

Phase-Based Progress Estimates

Combinedfor Suicide

This randomized comparative effectiveness trial will compare two evidence-based approaches to emergency care for youth ages 15-24 who present to the Emergency Department (ED) with suicidal ideation or behavior. OUtcomes will be monitored at baseline and at 3, 6 & 12 month follow-up assessments.

Ronald Reagan Medical Center (+4 Sites)David Goldston, PhD

Image of University of Alabama in Birmingham, United States.

Phase-Based Progress Estimates

Serabelisibfor Solid Tumors, Advanced Solid Tumors

This trial will study if a drug combo is safe and effective with the goal of reducing side effects.

University of Alabama (+12 Sites)Vicky MakkerFaeth Therapeutics

Image of University of Alabama at Birmingham in Birmingham, United States.

Phase-Based Progress Estimates

Tirzepatide Dose 2for Diabetes Mellitus

This trial is testing the safety and effectiveness of tirzepatide compared to placebo in children and adolescents with type 2 diabetes who are also taking metformin, basal insulin, or both. The study will last 60 weeks with 14 clinic visits and 6 phone visits.

University of Alabama at Birmingham (+15 Sites)1-877-CTLilly (1877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)Eli Lilly and Company

Image of Alaska Oncology and Hematology, LLC. in Anchorage, United States.

Phase-Based Progress Estimates

Pembrolizumabfor Non-small Cell Lung Cancer

This trial is testing a new combination therapy for advanced or metastatic non-small-cell lung cancer (NSCLC) that has not responded to other treatments. The primary objectives are to assess the objective response rate (ORR) and to determine the recommended Phase 2 dose (RP2D) of the new therapy.

Alaska Oncology and Hematology, LLC. (+11 Sites)Gilead Study DirectorMerck Sharp & Dohme LLC

Image of Piedmont Hospital in Atlanta, United States.

Phase-Based Progress Estimates

SAPIEN X4 THVfor Aortic Valve Stenosis

This trial is testing a new heart valve to see if it is safe and effective for people with a certain type of heart problem.

Piedmont Hospital (+20 Sites)Rahul P. Sharma, MBBSEdwards Lifesciences

Image of Clinical Research Center of Alabama in Birmingham, United States.

Phase-Based Progress Estimates

AK002for Dermatitis

This trial is testing a new drug to see if it's effective and safe for people with moderate-to-severe eczema that isn't controlled by other treatments.

Clinical Research Center of Alabama (+85 Sites)Craig Paterson, MDAllakos Inc.

Image of Highlands Oncology Group in Springdale, United States.

Phase-Based Progress Estimates

Avelumabfor Urothelial Cancer

FDA Approved Drug

This trial is to provide continued treatment and safety follow-up for eligible participants who are benefiting from the study intervention in the Avelumab parent studies.

FDA Approved Drug

Highlands Oncology Group (+20 Sites)Pfizer CT.gov Call CenterPfizer

Image of Innovative Clinical Research Institute (ICRI) in Whittier, United States.

Phase-Based Progress Estimates

Etavopivat Tabletsfor Thalassemia

This trial will evaluate the safety and clinical activity of a new drug, etavopivat, in patients with thalassemia or sickle cell disease. The goal is to see if the drug can lower the number of red blood cell transfusions required and increase hemoglobin.

Innovative Clinical Research Institute (ICRI) (+9 Sites)Von Potter, MDForma Therapeutics, Inc.

Image of Baptist Hospital in Miami, United States.

Phase-Based Progress Estimates

AerSleep IIfor Sleep Apnea, Obstructive

This trial is testing a new device to treat sleep apnea in people who can't use CPAP. The device will be used at home for 24 weeks to see if it is safe and effective.

Baptist Hospital (+15 Sites)Kingman P. Strohl, M.D.Sommetrics, Inc.

Image of Illinois CancerCare-Bloomington in Bloomington, United States.

Phase-Based Progress Estimates

Fractionated Stereotactic Radiation Therapyfor Astrocytoma

FDA Approved Drug

This trial is testing a combination of therapies to see if they're more effective than radiation therapy alone in treating recurrent glioblastoma.

FDA Approved Drug

Illinois CancerCare-Bloomington (+67 Sites)Stephen J Bagley

Image of Arizona Arthritis in Glendale, United States.

Phase-Based Progress Estimates

MT-7117for Sclerosis

This trial is testing a new treatment for people with a certain type of systemic sclerosis. The treatment will be evaluated based on how much it improves the subjects' condition at Week 52.

Arizona Arthritis (+15 Sites)Head of Medical ScienceMitsubishi Tanabe Pharma Development America, Inc.

Image of Massachusetts General Hospital in Boston, United States.

Phase-Based Progress Estimates

SRK-181for Malignancies

This trial is testing a new drug, SRK-181, to see if it is safe and effective in treating solid tumors. The study will test different doses of the drug alone and in combination with another anti-cancer drug. The trial is divided into 3 parts, with a long-term extension phase.

Massachusetts General Hospital (+11 Sites)Lu Gan, MDScholar Rock, Inc.

Image of University of Southern California in Los Angeles, United States.

Phase-Based Progress Estimates

ATP128for Cancer of Rectum

This trial is assessing the safety and tolerability of the ATP128 vaccine when given alone or in combination with BI 754091. The trial will also assess the efficacy of the combination of ATP128 and VSV-GP128 when given in combination with BI 754091 in patients with microsatellite stable colorectal cancer.

University of Southern California (+5 Sites)Scott KopetzBoehringer Ingelheim

Image of Cedars-Sinai Medical Center in Los Angeles, United States.

Phase-Based Progress Estimates

Hepatocellular Carcinoma (HCC) Partfor Carcinoma, Hepatocellular

FDA Approved Drug

The primary objective of this study is to assess the safety and tolerability and to determine the recommended Phase 2 dose (RP2D) of E7386 in combination with other anticancer drug(s).

FDA Approved Drug

Cedars-Sinai Medical Center (+4 Sites)Eisai Inc.

Image of Cedars-Sinai Medical Center in Los Angeles, United States.

Phase-Based Progress Estimates

ASTX295for Tumors, Solid

This trial is testing a new drug, ASTX295, to see if it is safe and effective in treating people with certain types of cancer. The trial will have two parts, with the first part testing different doses of the drug to see what is safe and what works best.

Cedars-Sinai Medical Center (+18 Sites)Kim-Hein Dao, DO, PhDAstex Pharmaceuticals, Inc.

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Phase-Based Progress Estimates

Cisplatinfor Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

FDA Approved Drug

This trial is studying a lower dose of radiation therapy with nivolumab for patients with HPV-positive oropharyngeal cancer that is early in growth.

FDA Approved Drug

University of Alabama at Birmingham Cancer Center (+99 Sites)Sue S Yom

Image of Los Angeles County-USC Medical Center in Los Angeles, United States.

Phase-Based Progress Estimates

Eribulin Mesylatefor Pelvic Neoplasms

FDA Approved Drug

This trial is testing atezolizumab with or without eribulin mesylate to see if it can help people with urothelial cancer that has come back or spread to other parts of the body.

FDA Approved Drug

Los Angeles County-USC Medical Center (+15 Sites)David I Quinn

Image of Katmai Oncology Group in Anchorage, United States.

Phase-Based Progress Estimates

Atezolizumabfor Lynch Syndrome

FDA Approved Drug

This trial is testing a combination of chemotherapy drugs with atezolizumab to see if it is more effective than chemotherapy alone in treating patients with stage III colon cancer. Atezolizumab is an immunotherapy drug that may help the body's immune system attack the cancer.

FDA Approved Drug

Katmai Oncology Group (+99 Sites)Frank A Sinicrope

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Phase-Based Progress Estimates

Ipilimumabfor Serous Cystadenocarcinoma

FDA Approved Drug

This trial is studying nivolumab and ipilimumab in treating patients with rare tumors.

FDA Approved Drug

University of Alabama at Birmingham Cancer Center (+99 Sites)Sandip P Patel

25 Clinical Trials Los Angeles Near Me

Top Cities for Clinical Trials Los Angeles

Image of Los Angeles in California.

Los Angeles

372Active Trials

Kaiser Permanente Los Angeles Medical CenterTop Active Site

Image of New York in New York.

New York

155Active Trials

Memorial Sloan Kettering Cancer CenterTop Active Site